Evaluation of ST-segment agreement between Spandan Pro and gold standard electrocardiogram for percutaneous coronary intervention decision-making
Unlocking Enterprise Efficiency with AI
ST-elevation myocardial infarction (STEMI) demands rapid diagnosis and treatment. Delays increase mortality, and traditional ECG access is often limited, especially in remote or resource-constrained environments.
The Spandan Pro, a smartphone-based ECG device, offers a portable and efficient solution for timely Percutaneous Coronary Intervention (PCI) decision-making in STEMI patients.
Executive Impact: Key Findings at a Glance
Bland-Altman analysis revealed good agreement between ST-segment elevation measurements from Spandan Pro and gold standard ECGs, with clinically insignificant mean differences (-0.08 mV to 0.05 mV) across all leads. This confirms the Spandan Pro's reliability.
184
Patients Assessed
55
PCI Recommended
±0.05mV
Max Mean Difference (mV)
80%
Estimated Cost Savings
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
Diagnostic Accuracy
Clinical Workflow
Cost-Benefit Analysis
The study rigorously compared ST-segment elevation measurements from the Spandan Pro device against the gold standard ECG, establishing high diagnostic accuracy for STEMI detection.
| Lead | Mean Difference (mV) | Interpretation |
|---|---|---|
| V1 | -0.002 | Negligible bias, high agreement |
| V2 | 0.05 | Minor bias, acceptable agreement |
| V3 | -0.08 | Slight bias, clinically acceptable |
| V4 | -0.05 | Minor bias, acceptable |
| V5 | -0.04 | Narrow LOA, strong agreement |
| V6 | 0 | No bias, very high agreement |
| I | -0.02 | Extremely consistent |
| aVL | 0.01 | Very accurate |
| II | -0.03 | Small, consistent differences |
| III | -0.01 | Highly accurate |
| aVF | -0.01 | Consistent and reliable |
Spandan Pro's integration into the clinical pathway significantly streamlines the diagnosis and management of STEMI, particularly in prehospital and resource-limited settings.
Streamlined STEMI Pathway with Spandan Pro (Figure 1)
Chest pain
→
Spandan Pro ECG
→
STEMI confirmed
→
Timely PCI
→
Better outcomes
The Spandan Pro offers significant cost efficiencies compared to traditional ECG devices, making advanced cardiac diagnostics more accessible and scalable for enterprises.
Enterprises can realize an estimated
80% Cost Reduction in Equipmentin equipment costs by adopting Spandan Pro for STEMI diagnosis, democratizing access to crucial cardiac care.
Calculate Your Potential ROI
Estimate the financial and operational benefits your organization could achieve by integrating AI-powered solutions.
Estimated Annual Savings
$0
Hours Reclaimed Annually
0
Your Enterprise AI Implementation Roadmap
The Spandan Pro improves patient outcomes by enabling faster triage and diagnosis, making it a valuable tool in low-resource settings, supporting early PCI referrals, and serving as a reliable prehospital diagnostic tool.
Phase 1: Needs Assessment & Pilot Program
Define specific use cases and integrate Spandan Pro into a pilot department to assess real-world performance and gather initial feedback.
Phase 2: Training & Integration
Conduct comprehensive training for medical staff. Integrate Spandan Pro data into existing electronic health record (EHR) systems for seamless workflow.
Phase 3: Rollout & Scaling
Expand Spandan Pro deployment across multiple departments or facilities, leveraging its portability for wider accessibility, especially in remote areas.
Phase 4: Ongoing Optimization & Support
Continuously monitor device performance, gather user insights, and provide ongoing technical support and software updates to maximize long-term benefits.
Ready to Transform Your Operations?
Leverage the power of AI to achieve unprecedented efficiency and innovation. Our experts are ready to guide you.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat